Scarica l'app Stockscreener
2.22
0.91%
0.02
Pre-mercato:
2.20
-0.02
-0.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BTAI Giù?
Forum
Previsione
Precedente Chiudi:
$2.20
Aprire:
$2.18
Volume 24 ore:
746.59K
Relative Volume:
0.08
Capitalizzazione di mercato:
$35.54M
Reddito:
$1.38M
Utile/perdita netta:
$-179.05M
Rapporto P/E:
-0.3616
EPS:
-6.14
Flusso di cassa netto:
$-155.03M
1 W Prestazione:
-17.16%
1M Prestazione:
-20.14%
6M Prestazione:
+32.14%
1 anno Prestazione:
+281.12%
Intervallo 1D:
$2.1336
$2.3092
Intervallo di 1 settimana:
$2.1336
$2.70
Portata 52W:
$0.16
$8.08
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
Nome
Bioxcel Therapeutics Inc
Settore
Industria
Telefono
203-643-8060
Indirizzo
555 LONG WHARF DRIVE, NEW HAVEN, CT
Confronta BTAI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
2.22 | 43.22M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.44 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.90 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.74 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
814.17 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
313.54 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-21 | Downgrade | UBS | Buy → Neutral |
| 2023-08-15 | Downgrade | Mizuho | Buy → Neutral |
| 2023-07-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-03-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-12-01 | Aggiornamento | Goldman | Sell → Neutral |
| 2022-07-07 | Iniziato | Mizuho | Buy |
| 2022-04-06 | Reiterato | BofA Securities | Buy |
| 2021-11-15 | Downgrade | Goldman | Neutral → Sell |
| 2021-04-09 | Iniziato | Berenberg | Buy |
| 2021-02-01 | Iniziato | UBS | Buy |
| 2020-10-30 | Iniziato | Goldman | Buy |
| 2020-09-02 | Iniziato | Jefferies | Buy |
| 2020-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-04 | Iniziato | Guggenheim | Buy |
| 2020-04-01 | Iniziato | BofA/Merrill | Buy |
| 2020-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-08 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-12 | Iniziato | SunTrust | Buy |
Mostra tutto
Bioxcel Therapeutics Inc Borsa (BTAI) Ultime notizie
Will BioXcel Therapeutics Inc. benefit from macro trendsJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
Why BioXcel Therapeutics Inc. stock could see breakout soonQuarterly Profit Report & Free Technical Pattern Based Buy Signals - newser.com
Key metrics from BioXcel Therapeutics Inc.’s quarterly dataInsider Buying & Expert Verified Stock Movement Alerts - newser.com
Will BioXcel Therapeutics Inc. (BX20) stock recover faster than industryMarket Rally & Weekly Breakout Opportunity Watchlist - newser.com
How BioXcel Therapeutics Inc. (BX20) stock reacts to stronger dollarJuly 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - newser.com
BioXcel Therapeutics Inc. stock chart pattern explainedJuly 2025 Volume & Free Community Consensus Stock Picks - newser.com
How analysts revise price targets for BioXcel Therapeutics Inc. (BX20) stockGold Moves & AI Enhanced Trading Signals - newser.com
Building trade automation scripts for BioXcel Therapeutics Inc.Earnings Trend Report & Long Hold Capital Preservation Plans - newser.com
Sentiment analysis tools applied to BioXcel Therapeutics Inc.July 2025 Retail & Reliable Price Breakout Alerts - newser.com
Published on: 2025-10-20 19:22:51 - newser.com
Published on: 2025-10-20 07:46:17 - newser.com
Strategies to average down on BioXcel Therapeutics Inc.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
Is BioXcel Therapeutics Inc. stock supported by strong fundamentalsQuarterly Trade Summary & Daily Profit Focused Stock Screening - nchmf.gov.vn
Is BioXcel Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Volume & Short-Term Trading Alerts - nchmf.gov.vn
How BioXcel Therapeutics Inc. (BX20) stock responds to bond marketWeekly Gains Report & Community Consensus Picks - nchmf.gov.vn
Aug EndMonth: Will BioXcel Therapeutics Inc. stock recover faster than peers2025 Technical Patterns & Weekly Breakout Stock Alerts - nchmf.gov.vn
BioXcel Therapeutics, Inc.Common Stock (NQ: BTAI - FinancialContent
Published on: 2025-10-18 01:05:28 - nchmf.gov.vn
Why BioXcel Therapeutics Inc. (BX20) stock is a must watch tickerJuly 2025 Short Interest & Stepwise Trade Execution Plans - nchmf.gov.vn
BioXcel stock rating reiterated at Buy by H.C. Wainwright on trial results - Investing.com Canada
BioXcel Therapeutics IncNo Serious Adverse Events Reported in Study - 富途牛牛
Will BioXcel Therapeutics Inc. stock recover faster than peersMarket Activity Summary & Trade Opportunity Analysis - newser.com
BioXcel Therapeutics Rings the Nasdaq Stock Market Closing Bell - Nasdaq
BioXcel Therapeutics Rings the Closing Bell - Nasdaq
BioXcel Therapeutics (BTAI) Reports Positive Study Results Suppo - GuruFocus
BioXcel reports positive correlation study results for BXCL501 By Investing.com - Investing.com Nigeria
BioXcel Announces Positive SERENITY At Home Study Results - TipRanks
BioXcel Reports Results From Correlation Study Related To Efficacy Outcomes From SERENITY Trial - Nasdaq
BioXcel reports positive correlation study results for BXCL501 - Investing.com
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes - The Manila Times
Bioxcel Therapeutics Inc Azioni (BTAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.71%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):